Matthew Dagley

Matthew Dagley has a diverse work experience spanning over several years. Matthew currently serves as the Director of Marketing and Development at CVRx | Barostim since May 2022. Prior to this, they worked as the Director of Field Operations at SentiAR from October 2021 to May 2022.

Matthew also held various roles at CVRx, starting as a Business Development Specialist from March 2020 to October 2021. In this position, they were responsible for the commercial launch and market adoption of Barostim Therapy. Matthew later became the BeAT-HF Account Manager from March 2017 to March 2020, where they achieved significant success by building the second-highest performing territory in the BeAT-HF Pivotal Trial and influencing new referral patterns.

Before CVRx, Matthew worked at Abbott as a Sales Representative in Cardiac Rhythm Management from January 2013 to March 2017. Matthew also gained experience as a Direct Sales Representative at BIOTRONIK from August 2008 to January 2013.

Matthew's earlier work experience includes roles at the University of Chicago Medicine as a Cardiac Cath. Specialist/ Electrophysiology from September 2007 to August 2008, at All Saints Hospital as a Cardiovascular Diagnostic Tech III/ Pacemaker from October 2006 to August 2007, at Condell Medical Center as an Exercise Physiologist from June 2006 to August 2006, and at Bronson Methodist Hosp. as a Microbiology Accession Tech. from May 2004 to June 2006.

Matthew Dagley attended Western Michigan University from 2001 to 2006, graduating with a Bachelor's of Science degree in Exercise Science. During this time, they also pursued a B.S. degree in Physiology, completing the program in 2005.